Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer

Journal of Endourology

Volumn 22, Issue 7, 2008, Pages 1485-1489

  Skolarus, T A ^a,c   Bhayani, S B ^a   Chiang, H C ^a   Brandes, S B ^a   Kibel, A S ^a   Landman, J ^b   Figenshau, R S ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER STAGING; CHYLOUS ASCITES; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; EJACULATION DISORDER; GERM CELL TUMOR; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; LUNG EMBOLISM; LYMPH NODE DISSECTION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RHABDOMYOSARCOMA; TESTIS CANCER; TREATMENT OUTCOME; VOMITING;

ADULT; DISSECTION; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; NEOPLASM STAGING; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS;

EID: 50649086322     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.0442     Document Type: Article

References (20)

1. Nielsen ME, Lima G, Schaeffer EM, Porter J, Cadeddu JA, Tuerk I, Kavoussi LR. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. Urology 2007;70:1168-1172.
2. Albqami N, Janetschek G. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol 2005;19:683-692.
3. Bhayani SB, Ong A, Oh WK, Kantoff PW, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: A long-term update. Urology 2003;62:324-327.
4. Allaf ME, Bhayani SB, Link RE, Schaeffer EM, Varkarakis JM, Shadpour P, Lima G, Kavoussi ER. Laparoscopic retroperitoneal lymph node dissection: Duplication of open technique. Urology 2005;65:575-577.
5. Foster RS, Donohue JP. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma. J Urol 2000;163:1788-1792.
6. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989. Br J Urol 1993;71:326-335.
7. Beck SD, Peterson MD, Bihrle R, Donohue JP, Foster RS. Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients. J Urol 2007;178:504-506.
8. McDougall E, Clayman RV, Elashry OM. Laparoscopic radical nephrectomy for renal tumor: The Washington University experience. J Urol 1996;155:1180-1185.
9. Winfield HN, Donovan JF, Lund GO, Kreder KJ, Stanley KE, Brown BP, Loening SA, Clayman RV. Laparoscopic partial nephrectomy: Initial experience and comparison to the open surgical approach. J Urol 1995;153:1409-1414.
10. Hobisch A, Tonnemann J, Janetschek G. Morbidity and quality of life after open versus laparoscopic retroperitoneal lymphadenectomy for testicular tumour - the patient's view. In: Jones W, Appleyard I, Hamden P, Joffe J, eds. Germ Cell Tumours VI. London: John Libbey & Co, 1998, p 277.
11. Poulakis V, Skriapas K, de Vries R, Dillenburg W, Ferakis N, Witzsch U, Becht E. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: A comparison study. Urology 2006;68:154-160.
12. Davol P, Sumfest J, Rukstalis D. Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 2006;67:199.
13. Hamilton RJ, Finelli A. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ-cell tumors: Current status. Urol Clin North Am 2007;34:159-169.
14. van den Belt-Dusebout AW, de Wit R, Gietema JA, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370-4378.
15. Travis LB, Fosså SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 2005;97:1354-1365.
16. Wiener ES, Anderson JR, Ojimba JI, et al. Controversies in the management of paratesticular rhabdomyosarcoma: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg 2001;10:146-152.
17. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): Modifications of technique and impact on ejaculation. J Urol 1993;149:237-243.
18. Williams SD, Stablein DM, Einhorn LH, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987;317:1433-1438.
19. Palese MA, Su LM, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 2002;60:130-134.
20. Ost MC, VanderBrink BA, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection (LRLND) for high-risk pediatric patients with para-testicular rhabdomyosarcoma. MP21-07, WCE 2006.